Rigel Pharmaceuticals | RIGL - Loan Capital

Stock Price
29.48
Daily Change
-0.15 -0.51%
Monthly
-13.68%
Yearly
49.64%
Q1 Forecast
33.68

Rigel Pharmaceuticals reported $0 in Loan Capital for its fiscal quarter ending in September of 2024.





Loan Capital Change Date
Agenus USD 23.6M 448K Sep/2025
Amgen USD 50B 2.43B Dec/2025
Anika Therapeutics USD 0 0 Mar/2025
Arrowhead Research USD 538.1M 323.22M Dec/2025
AstraZeneca USD 26.14B 19.58B Dec/2025
BioMarin Pharmaceutical USD 597.18M 513K Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Halozyme Therapeutics USD 2.14B 1.34B Dec/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Intrexon USD 0 198.67M Jun/2024
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
Karyopharm Therapeutics USD -0.93 0.67 Dec/2024
Ligand Pharmaceuticals USD 445.49M 445.44M Sep/2025
MacroGenics USD 70.26M 4K Sep/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Pfizer USD 57.41B 93M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Rigel Pharmaceuticals USD 0 0 Sep/2024
Sangamo BioSciences USD 0 0 Jun/2022
Ultragenyx Pharmaceutical USD 763.74M 19.02M Sep/2025
Veracyte USD 0 0 Mar/2025